The US Food and Drug Administration is funding a study to assess how biosensors can be used to capture patient-centric endpoints in clinical trials.
The Yale University-Mayo Clinic Center of Excellence in Regulatory Science and Innovation (CERSI) received funding from FDA to conduct the study, which will enroll 150 recently discharged patients with
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?